跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KOSELUGO 25 mg CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KOSELUGO 25 mg CAPSULAS DURAS
Approved
STANDARD
KOSELUGO 25 mg CAPSULAS DURAS
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 27, 2021
Approval ID
14c7234ebc7793ad
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
14c7234ebc7793ad
Drug Cima Aemps Name
KOSELUGO 25 mg CAPSULAS DURAS
Register Number
1211552002
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Alexion Pharma Spain S.L.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2021-07-27
Dosage Form
CÁPSULA DURA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
ASTRAZENECA AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
SELUMETINIB SULFATO
30,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 27, 2021
Approval ID
14c7234ebc7793ad
Type
Standard
Back to CIMA-AEMPS Approvals